Is Immunome, Inc. (IMNM) a Buy, Sell, or Hold?
Immunome, Inc.
NASDAQ:IMNM
$22.92 USD
$0.33 (1.46%)
- Volume
- 1.9M
- Average Volume
- 1.32M
- Market Capitalization
- $2.19B
- P/E Ratio
- -9.59
- Dividend Yield
- 0.00%
- Price Target
- $36.50
- Year High
- $27.65
- Year Low
- $8.48
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $21.68
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
24
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
32
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 1.46M
IMNM Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
IMNM Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Horn Kinney | officer: CHIEF BUSINESS OFFICER | 2026-07-07 | M-Exempt | 12.92 | 2026-07-09 |
| Horn Kinney | officer: CHIEF BUSINESS OFFICER | 2026-07-07 | M-Exempt | 12.92 | 2026-07-09 |
| Horn Kinney | officer: CHIEF BUSINESS OFFICER | 2026-07-07 | S-Sale | 25 | 2026-07-09 |
| Barchas Isaac | director | 2026-07-06 | S-Sale | 24.11 | 2026-07-07 |
| Barchas Isaac | director | 2026-07-07 | S-Sale | 24.2 | 2026-07-07 |
| Lechleider Robert | officer: Chief Medical Officer | 2026-07-02 | M-Exempt | 8.73 | 2026-07-07 |
| Lechleider Robert | officer: Chief Medical Officer | 2026-07-02 | M-Exempt | 8.73 | 2026-07-07 |
| Lechleider Robert | officer: Chief Medical Officer | 2026-07-02 | S-Sale | 21.95 | 2026-07-07 |
| Lechleider Robert | officer: Chief Medical Officer | 2026-07-02 | S-Sale | 22.76 | 2026-07-07 |
| Lechleider Robert | officer: Chief Medical Officer | 2026-07-02 | S-Sale | 23.44 | 2026-07-07 |
| Barchas Isaac | director | 2026-06-30 | S-Sale | 21.12 | 2026-07-02 |
| Barchas Isaac | director | 2026-07-02 | S-Sale | 22.35 | 2026-07-02 |
| Barchas Isaac | director | 2026-07-02 | S-Sale | 23.33 | 2026-07-02 |
| Lechleider Robert | officer: Chief Medical Officer | 2026-06-25 | M-Exempt | 8.73 | 2026-06-29 |
| Lechleider Robert | officer: Chief Medical Officer | 2026-06-25 | M-Exempt | 8.73 | 2026-06-29 |
| Lechleider Robert | officer: Chief Medical Officer | 2026-06-25 | S-Sale | 19.56 | 2026-06-29 |
| Lechleider Robert | officer: Chief Medical Officer | 2026-06-25 | S-Sale | 20.66 | 2026-06-29 |
| Rosett Max | officer: Chief Financial Officer | 2026-06-15 | M-Exempt | 1.05 | 2026-06-17 |
| Rosett Max | officer: Chief Financial Officer | 2026-06-15 | S-Sale | 18.23 | 2026-06-17 |
| Rosett Max | officer: Chief Financial Officer | 2026-06-15 | M-Exempt | 1.05 | 2026-06-17 |
| SWAIN SANDRA M | director | 2026-06-10 | A-Award | 18.16 | 2026-06-12 |
| WAGENHEIM PHILIP | director | 2026-06-10 | A-Award | 18.16 | 2026-06-12 |
| BIENAIME JEAN JACQUES | director | 2026-06-10 | A-Award | 18.16 | 2026-06-12 |
| Boylan James P | director | 2026-06-10 | A-Award | 18.16 | 2026-06-12 |
| Barchas Isaac | director | 2026-06-10 | A-Award | 18.16 | 2026-06-12 |
| SCHAFER CAROL | director | 2026-06-10 | A-Award | 18.16 | 2026-06-12 |
| BIENAIME JEAN JACQUES | director | 2026-06-05 | P-Purchase | 19.27 | 2026-06-09 |
| BIENAIME JEAN JACQUES | director | 2026-06-05 | S-Sale | 19.44 | 2026-06-09 |
| BIENAIME JEAN JACQUES | director | 2026-06-05 | P-Purchase | 19.46 | 2026-06-09 |
| BIENAIME JEAN JACQUES | director | 2026-06-05 | P-Purchase | 19.48 | 2026-06-09 |
| BIENAIME JEAN JACQUES | director | 2026-06-05 | S-Sale | 19.41 | 2026-06-09 |
| BIENAIME JEAN JACQUES | director | 2026-05-15 | P-Purchase | 20.7 | 2026-05-19 |
| Higgins Jack | officer: Chief Scientific Officer | 2026-04-02 | S-Sale | 21.64 | 2026-04-03 |
| Rosett Max | officer: Chief Financial Officer | 2026-04-02 | M-Exempt | 1.35 | 2026-04-03 |
| Rosett Max | officer: Chief Financial Officer | 2026-04-02 | M-Exempt | 1.05 | 2026-04-03 |
| Rosett Max | officer: Chief Financial Officer | 2026-04-02 | M-Exempt | 1.05 | 2026-04-03 |
| Rosett Max | officer: Chief Financial Officer | 2026-04-02 | S-Sale | 21.91 | 2026-04-03 |
| Rosett Max | officer: Chief Financial Officer | 2026-04-02 | S-Sale | 22.48 | 2026-04-03 |
| Rosett Max | officer: Chief Financial Officer | 2026-04-02 | M-Exempt | 1.35 | 2026-04-03 |
| Higgins Jack | officer: Chief Scientific Officer | 2026-03-30 | G-Gift | 0 | 2026-04-01 |
| SIEGALL CLAY B | director, officer: President and CEO | 2026-03-27 | P-Purchase | 19.67 | 2026-03-31 |
| WAGENHEIM PHILIP | director | 2026-03-20 | S-Sale | 20.47 | 2026-03-23 |
| WAGENHEIM PHILIP | director | 2026-03-23 | S-Sale | 20.65 | 2026-03-23 |
| BIENAIME JEAN JACQUES | director | 2026-03-11 | P-Purchase | 21.55 | 2026-03-12 |
| BIENAIME JEAN JACQUES | director | 2026-03-10 | P-Purchase | 22.12 | 2026-03-12 |
| SIEGALL CLAY B | director, officer: President and CEO | 2025-12-30 | P-Purchase | 21.15 | 2025-12-30 |
| Barchas Isaac | director | 2025-12-22 | S-Sale | 21.72 | 2025-12-23 |
| Barchas Isaac | director | 2025-12-22 | S-Sale | 22.34 | 2025-12-23 |
| Higgins Jack | officer: Chief Scientific Officer | 2025-12-19 | G-Gift | 0 | 2025-12-22 |
| Higgins Jack | officer: Chief Scientific Officer | 2025-12-19 | G-Gift | 0 | 2025-12-22 |
| Higgins Jack | officer: Chief Scientific Officer | 2025-12-19 | G-Gift | 0 | 2025-12-22 |
| Higgins Jack | officer: Chief Scientific Officer | 2025-12-19 | G-Gift | 0 | 2025-12-22 |
| SIEGALL CLAY B | director, officer: President and CEO | 2025-12-19 | P-Purchase | 20.48 | 2025-12-22 |
| SIEGALL CLAY B | director, officer: President and CEO | 2025-12-19 | G-Gift | 0 | 2025-12-22 |
| Tsai Philip | officer: Chief Technical Officer | 2025-12-19 | P-Purchase | 20.49 | 2025-12-22 |
| SIEGALL CLAY B | director, officer: President and CEO | 2025-12-18 | P-Purchase | 21.5 | 2025-12-18 |
| Higgins Jack | officer: Chief Scientific Officer | 2025-09-10 | M-Exempt | 1.35 | 2025-09-11 |
| Higgins Jack | officer: Chief Scientific Officer | 2025-09-10 | M-Exempt | 1.35 | 2025-09-11 |
| Tsai Philip | officer: Chief Technical Officer | 2025-07-29 | A-Award | 10.6 | 2025-07-31 |
| Rosett Max | officer: Chief Financial Officer | 2025-07-29 | A-Award | 10.6 | 2025-07-31 |
| Lechleider Robert | officer: Chief Medical Officer | 2025-07-29 | A-Award | 10.6 | 2025-07-31 |
| Horn Kinney | officer: CHIEF BUSINESS OFFICER | 2025-07-29 | A-Award | 10.6 | 2025-07-31 |
| Higgins Jack | officer: Chief Scientific Officer | 2025-07-29 | A-Award | 10.6 | 2025-07-31 |
| SIEGALL CLAY B | director, officer: President and CEO | 2025-07-29 | A-Award | 10.6 | 2025-07-31 |
| Stoneman Sandra G. | officer: CHIEF LEGAL OFFICER & GC | 2025-07-29 | A-Award | 10.6 | 2025-07-31 |
| Boylan James P | director | 2025-06-10 | A-Award | 9.57 | 2025-06-12 |
| SCHAFER CAROL | director | 2025-06-10 | A-Award | 9.57 | 2025-06-12 |
| WAGENHEIM PHILIP | director | 2025-06-10 | A-Award | 9.57 | 2025-06-12 |
| Barchas Isaac | director | 2025-06-10 | A-Award | 9.57 | 2025-06-12 |
| BIENAIME JEAN JACQUES | director | 2025-06-10 | A-Award | 9.57 | 2025-06-12 |
| SWAIN SANDRA M | director | 2025-06-10 | A-Award | 9.57 | 2025-06-12 |
| BIENAIME JEAN JACQUES | director | 2025-06-03 | P-Purchase | 9.38 | 2025-06-03 |
| Higgins Jack | officer: Chief Scientific Officer | 2025-03-27 | M-Exempt | 1.35 | 2025-03-28 |
| Higgins Jack | officer: Chief Scientific Officer | 2025-03-27 | M-Exempt | 1.35 | 2025-03-28 |
| BIENAIME JEAN JACQUES | director | 2025-03-25 | P-Purchase | 7.78 | 2025-03-26 |
| SIEGALL CLAY B | director, officer: President and CEO | 2025-03-26 | P-Purchase | 7.29 | 2025-03-26 |
| BIENAIME JEAN JACQUES | director | 2025-03-24 | P-Purchase | 8.21 | 2025-03-25 |
| Tsai Philip | officer: Chief Technology Officer | 2025-03-24 | P-Purchase | 8.42 | 2025-03-25 |
| SIEGALL CLAY B | director, officer: President and CEO | 2025-01-31 | P-Purchase | 7.75 | 2025-02-03 |
| SIEGALL CLAY B | director, officer: President and CEO | 2024-11-22 | P-Purchase | 9.7787 | 2024-11-25 |
| SIEGALL CLAY B | director, officer: President and CEO | 2024-11-21 | P-Purchase | 9.5412 | 2024-11-25 |
| Lechleider Robert | officer: Chief Medical Officer | 2024-11-21 | P-Purchase | 9.478 | 2024-11-25 |
| Tsai Philip | officer: Chief Technology Officer | 2024-11-21 | P-Purchase | 9.43 | 2024-11-25 |
| Rosett Max | officer: Chief Financial Officer | 2024-09-19 | M-Exempt | 1.05 | 2024-09-20 |
| Rosett Max | officer: Chief Financial Officer | 2024-09-19 | M-Exempt | 1.05 | 2024-09-20 |
| Rosett Max | officer: Chief Financial Officer | 2024-09-19 | S-Sale | 16.01 | 2024-09-20 |
| BIENAIME JEAN JACQUES | director | 2024-08-16 | P-Purchase | 13.944 | 2024-08-19 |
| Higgins Jack | officer: Chief Scientific Officer | 2024-08-15 | M-Exempt | 1.35 | 2024-08-19 |
| Higgins Jack | officer: Chief Scientific Officer | 2024-08-15 | M-Exempt | 1.35 | 2024-08-19 |
| Higgins Jack | officer: Chief Scientific Officer | 2024-08-15 | S-Sale | 13.925 | 2024-08-19 |
| Higgins Jack | officer: Chief Scientific Officer | 2024-08-19 | G-Gift | 0 | 2024-08-19 |
| SIEGALL CLAY B | director, officer: President and CEO | 2024-08-09 | A-Award | 12.92 | 2024-08-13 |
| Stoneman Sandra G. | officer: CHIEF LEGAL OFFICER & GC | 2024-08-09 | A-Award | 12.92 | 2024-08-13 |
| Horn Kinney | officer: CHIEF BUSINESS OFFICER | 2024-08-09 | A-Award | 12.92 | 2024-08-13 |
| Turner Bruce | officer: Chief Strategy Officer | 2024-08-09 | A-Award | 12.92 | 2024-08-13 |
| Rosett Max | officer: EVP, Operations & CFO | 2024-08-09 | A-Award | 12.92 | 2024-08-13 |
| Lechleider Robert | officer: Chief Medical Officer | 2024-08-09 | A-Award | 12.92 | 2024-08-13 |
| Higgins Jack | officer: Chief Scientific Officer | 2024-08-09 | A-Award | 12.92 | 2024-08-13 |
| Tsai Philip | officer: Chief Technology Officer | 2024-06-17 | A-Award | 13.15 | 2024-06-18 |
| Tsai Philip | 2024-06-17 | 0 | 2024-06-18 |